SG Americas Securities’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.79M | Sell |
73,088
-64,061
| -47% | -$7.76M | ﹤0.01% | 924 |
|
|
2026
Q1 | $22.4M | Buy |
137,149
+70,387
| +105% | +$10.8M | 0.02% | 497 |
|
|
2025
Q4 | $11.6M | Buy |
66,762
+49,356
| +284% | +$9.01M | 0.01% | 698 |
|
|
2025
Q3 | $2.51M | Buy |
17,406
+13,305
| +324% | +$1.63M | 0.01% | 830 |
|
|
2025
Q2 | $413K | Sell |
4,101
-94
| -2% | -$7.19K | ﹤0.01% | 1792 |
|
|
2025
Q1 | $320K | Sell |
4,195
-680
| -14% | -$52K | ﹤0.01% | 2158 |
|
|
2024
Q4 | $337K | Sell |
4,875
-16,686
| -77% | -$1.2M | ﹤0.01% | 1683 |
|
|
2024
Q3 | $1.57M | Buy |
21,561
+19,084
| +770% | +$1.41M | 0.01% | 786 |
|
|
2024
Q2 | $166K | Sell |
2,477
-6,031
| -71% | -$234K | ﹤0.01% | 2267 |
|
|
2024
Q1 | $231K | Buy |
8,508
+4,695
| +123% | +$131K | ﹤0.01% | 1875 |
|
|
2023
Q4 | $118K | Sell |
3,813
-1,715
| -31% | -$44.5K | ﹤0.01% | 2633 |
|
|
2023
Q3 | $140K | Sell |
5,528
-166,225
| -97% | -$3.8M | ﹤0.01% | 2557 |
|
|
2023
Q2 | $3.62M | Buy |
171,753
+116,601
| +211% | +$2.21M | 0.03% | 492 |
|
|
2023
Q1 | $940K | Buy |
55,152
+44,838
| +435% | +$871K | 0.01% | 1179 |
|
|
2022
Q4 | $206K | Sell |
10,314
-6,774
| -40% | -$131K | ﹤0.01% | 2173 |
|
|
2022
Q3 | $368K | Sell |
17,088
-43,810
| -72% | -$1.05M | ﹤0.01% | 1813 |
|
|
2022
Q2 | $1.2M | Buy |
60,898
+50,539
| +488% | +$1.06M | 0.01% | 1137 |
|
|
2022
Q1 | $243K | Sell |
10,359
-34,105
| -77% | -$792K | ﹤0.01% | 2308 |
|
|
2021
Q4 | $1.21M | Sell |
44,464
-32,547
| -42% | -$931K | 0.01% | 1500 |
|
|
2021
Q3 | $2.12M | Buy |
77,011
+43,618
| +131% | +$1.14M | 0.01% | 1214 |
|
|
2021
Q2 | $950K | Buy |
33,393
+24,259
| +266% | +$720K | ﹤0.01% | 1592 |
|
|
2021
Q1 | $311K | Buy |
9,134
+5,898
| +182% | +$225K | ﹤0.01% | 2353 |
|
|
2020
Q4 | $108K | Sell |
3,236
-29,572
| -90% | -$1.08M | ﹤0.01% | 2997 |
|
|
2020
Q3 | $1.05M | Buy |
32,808
+17,516
| +115% | +$503K | 0.01% | 1144 |
|
|
2020
Q2 | $421K | Sell |
15,292
-5,029
| -25% | -$119K | ﹤0.01% | 2241 |
|
|
2020
Q1 | $326K | Buy |
20,321
+16,029
| +373% | +$380K | ﹤0.01% | 2167 |
|
|
2019
Q4 | $102K | Buy |
+4,292
| New | +$87.3K | ﹤0.01% | 2950 |
|
|
2019
Q2 | – | Sell |
-4,492
| Closed | -$131K | – | 3251 |
|
|
2019
Q1 | $131K | Sell |
4,492
-12,326
| -73% | -$319K | ﹤0.01% | 2871 |
|
|
2018
Q4 | $221K | Buy |
+16,818
| New | +$268K | ﹤0.01% | 2334 |
|
|
2018
Q3 | – | Sell |
-4,480
| Closed | -$106K | – | 3299 |
|
|
2018
Q2 | $106K | Sell |
4,480
-658
| -13% | -$16.9K | ﹤0.01% | 3040 |
|
|
2018
Q1 | $116K | Buy |
+5,138
| New | +$135K | ﹤0.01% | 2834 |
|
|
2017
Q4 | – | Sell |
-14,289
| Closed | -$446K | – | 3407 |
|
|
2017
Q3 | $446K | Buy |
14,289
+6,786
| +90% | +$129K | ﹤0.01% | 1933 |
|
|
2017
Q2 | $129K | Buy |
+7,503
| New | +$128K | ﹤0.01% | 2739 |
|
|
2017
Q1 | – | Sell |
-23,983
| Closed | -$317K | – | 3409 |
|
|
2016
Q4 | $317K | Buy |
+23,983
| New | +$327K | ﹤0.01% | 1995 |
|
|
2015
Q4 | – | Sell |
-9,478
| Closed | -$176K | – | 2838 |
|
|
2015
Q3 | $176K | Buy |
9,478
+4,940
| +109% | +$123K | ﹤0.01% | 1528 |
|
|
2015
Q2 | $111K | Buy |
+4,538
| New | +$103K | ﹤0.01% | 2306 |
|
|
2015
Q1 | – | Sell |
-7,589
| Closed | -$117K | – | 2791 |
|
|
2014
Q4 | $117K | Buy |
+7,589
| New | +$108K | ﹤0.01% | 2812 |
|
Other funds holding INSM
BBA
DGM
OAG
SG Americas Securities's INSM Position: Q2 2026 in Review
SG Americas Securities reduced its Insmed (INSM) stake by 47% in Q2 2026, selling an estimated $7.76M and leaving 73,088 shares worth $7.79M. The position accounts for ﹤0.01% of the portfolio, ranked #924.
SG Americas Securities first reported a position in INSM in Q4 2014 and has held it in 37 quarters since. The position peaked at $22.4M in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- SG Americas Securities held 73,088 shares of Insmed worth $7.79M as of Q2 2026.
- SG Americas Securities sold 64,061 Insmed shares in Q2 2026, an estimated $7.76M.
- Insmed made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #924 holding.
- SG Americas Securities first reported a position in Insmed in Q4 2014 and has held it in 37 quarters since.
- SG Americas Securities's Insmed position peaked at $22.4M in Q1 2026.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.